Ignite Creation Date:
2025-12-25 @ 12:59 AM
Ignite Modification Date:
2025-12-25 @ 11:13 PM
Study NCT ID:
NCT00891293
Status:
COMPLETED
Last Update Posted:
2011-01-25
First Post:
2009-04-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-30
First Submit QC Date:
None
Study First Post Date:
2009-05-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-05-06
Results First Submit QC Date:
None
Results First Post Date:
2009-07-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-01-22
Last Update Post Date:
2011-01-25
Last Update Post Date Type:
ESTIMATED